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CASE PRESENTATION
A 49-year-old transsexual man and infected by HIV1 for
20 years had received several antiretroviral drugs from
1999 to 2004. In 2004, he was successfully treated for
pulmonary tuberculosis and in August 2005 admitted to
hospital because of renal failure. Physical examination
disclosed apyrexia, a low-systolic blood pressure (100 mm
Hg) with extracellular dehydration and inappropriate
diuresis (3.5 l/day). Neurological examination disclosed
mild quadriparesis, a bilaterally positive Babinski’s sign,
and dysesthesia with severe gait disorder. Splenomegaly
lymphadenopathy or enlargement of the parotid glands
was not seen.
Biological findings at presentation are described in
Table 1. Plasma electrophoresis revealed polyclonal
hypergammaglobulinemia and a complete blood count
revealed a white blood cell count of 10 109/l with
5 109/l lymphocytes (CD4 count was 1131/mm3 and CD8
counts 3388/mm3). Serological tests for syphilis were
negative. HIV viral load was 60 000 copies/mm3.
Serum creatinine level was 444mmol/l. There was
inappropriate natriuresis (391 mmol/24 h) and distal
tubular acidosis. Proteinuria was 1.3 g/day and was
essentially composed of low-molecular-weight proteins;
urine sediment was positive for white and red blood cells
(10 cells/HPF (high-power field)). Ultrasonography showed
that kidneys were enlarged (150 mm each).
RENAL BIOPSY
A renal biopsy showed marked infiltration by mononuclear
cells, essentially CD8þ lymphocytes, with tubulitis and a
reduced number of tubules (Figures 1 and 2). Granzyme B, a
member of the lytic machinery of cytotoxic cells, could be
detected in areas of tubulitis. Some tubules were dilated and
contained hyaline material in their lumen. No mitotic figures
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Table 1 | Results of serum and urine chemical tests at
presentation
Variable
Normal
range
Values
in patient
Blood
Sodium (mmol/l) 137–143 137
Potassium (mmol/l) 3.5–4.5 5.2
Chloride (mmol/l) 97–105 109
Bicarbonate (mmol/l) 23–30 19
Urea (mmol/l) 3–7 20
Creatinine (mmol/l) 40–120 444
Protein (g/l) 65–75 98
Albumin (g/l) 38–45 21.7
Globulin (g/l) 16.5–30 75.9
White blood cell count (per mm3) 4000–10 000 10 000
Lymphocytes (per mm3) 1500–4000 5000
CD4+ cells (per mm3) 430–1367 1131
CD8+ cells (per mm3) 205–717 3388
Hemoglobine (g/dl) 12–18 9
Mean corpuscular volume (fl) 80–100 97
Platelets (per mm3) 150 000–400 000 276 000
HIV viral load (copies/mm3) 60 000
Urine
pH 5.5
Red blood cells (per HPF) o5 10
White blood cells (per HPF) o10 10
Sodium (mmol/l) 105
Potassium (mmol/l) 14
Chloride (mmol/l) 48
Urea (mmol/l) 121
Urinary total proteins (g/day) o0.15 1.3
Albumin (mg/l) o30 80
a1-macroglobulin (mg/l) o15 209
Retinol binding protein (mg/l) o0.5 41.4
Globulin (mg/l) o10 55.4
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were observed among infiltrating T cells. No epithelioid cells,
giant cell granuloma, or crystals were observed.
CLINICAL DIAGNOSIS
In this context of HIV infection, CD8 lymphocytosis and
acute interstitial nephritis, the diagnosis of a diffuse
infiltrative lymphocytosis syndrome (DILS) was suspected.
Spinal cord and cerebral magnetic resonance imaging
showed cervical and thoracic myelitis. Lumbar puncture yielded
a clear cerebro-spinal fluid with 36 white blood cells (70% of
which were CD8þ lymphocytes) and 0.92 g protein/l. Cerebro-
spinal fluid glucose concentration was normal. No pathogens
were found by poymerase chain reaction (PCR) (negative for
Epstein–Barr (EBV), JC virus, HTLV1, cytomegalo-
virus (CMV), VZV, HSV, Toxoplasma gondii, HHV8, and
mycobacterium).
Examination of bronchoalveolar lavage samples revealed
the presence of CD8þ lymphocytic alveolitis, but not of
pathogens. There was no mycobacterium in the gastric
aspirate samples.
CHARACTERIZATION OF CD8 LYMPHOCYTOSIS
We further characterized the circulating and visceral
lymphocytic expansion. T-cell receptor g-chain gene rearran-
gements were amplified using a gas chromatograph clamp
multiplex PCR procedure and analyzed by denaturing
gradient gel electrophoresis.1 With this technique, a domi-
nant T-cell clone appears as one, two, or four discrete bands
(depending on whether one or two g-chain alleles are
rearranged and if heteroduplexes are generated) emerging
above the smear corresponding to the polyclonal back-
ground. We detected the same weakly dominant T-cell clone
in blood and kidney specimens (Figure 3). Viral load for EBV
(determined from whole blood using quantitative real-time
PCR assay based on BALF5 gene2) ranged from 3.82 to
4.88 log/ml. The investigation of 30-bp deletion variant of the
LMP-1 gene of EBV was performed by amplification of its
C-terminal region:3 the EBV strain was characterized as a
wild-type variant (no deletion) during the 8 months of
biological follow-up, suggesting a low oncogenic potential.
Moreover, LMP1 expression was absent in lymphocytes
infiltrating the kidneys (data not shown).
CLINICAL FOLLOW-UP
After rehydration, creatinine levels decreased to 320mmol/l.
Corticosteroid treatment was introduced with bolus injections
of methylprednisolone (500 mg/day for 3 days) followed by
1 mg/kg daily dose of oral prednisone. Neurological symptoms
a
cb
Figure 1 | Renal biopsy findings. (a) Widespread expansion of the renal interstitium by large sheets of inflammatory cells. (b) The dense
cellular interstitial infiltrates are composed of lymphocytes, monocytes and plasma cells. (c) Alteration of the tubules with varying degree of
tubulitis and tubular destruction.
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progressively improved; within 2 weeks the size of the kidneys
had decreased to 130 mm each and serum creatinine lowered to
190mmol/l. Antiretroviral therapy combining lopinavir
(800 mg/day), ritonavir (200 mg/day), and efavirenz (600 mg/
day) was begun 1 month later. Two months after this full-dose
regimen, steroids were tapered progressively and completely
discontinued 5 months later (antiviral therapy was maintained).
Despite an undetectable HIV viral load under antiretroviral
therapy, renal failure along with neurological and sicca
symptoms returned 2 weeks after the steroids were discon-
tinued. Steroids were resumed (1 mg/kg/day) and tapered once
more as the renal disease responded to treatment. One year after
the initial presentation, under a maintenance regimen associat-
ing antiviral drugs and 0.1 mg/kg/day of prednisone, serum
creatinine was 142mmol/l, and the plasmatic clearance of the
glomerular tracer Chromium-51 ethylenediaminetetraacetic
acid (Cr51-EDTA) was 40.2 ml/min/1.73 m2.
DISCUSSION
DILS is a Gougerot–Sjo¨gren-like syndrome occurring in HIV-
positive patients.4 Most patients are adults (generally around
40-year old) who have been infected by HIV for some years,
from either sex, of all ethnic origins, present with bilateral
parotid gland enlargement and have had a history of sicca
symptoms for several months. Nowadays, respiratory symp-
toms (dyspnea), and liver or renal disease are rarely
associated (Table 2 summarizes the characteristic features
reported in DILS patients). The disease is due to a persistent,
circulating, and visceral CD8þ lymphocytic infiltration
potentially damaging multiple organs: mainly the salivary
glands, and occasionally the lungs (causing ‘lymphocytic
interstitial pneumonitis’), but also muscles, peripheral
nerves, the gastrointestinal tract, liver, and kidneys.5–9
Renal involvement during the DILS
Although DILS has been reported to affect kidneys in the
scant DILS literature, renal syndrome has been poorly
described if at all.6,7,10,11 The first case of biopsy-proven
lymphocytic interstitial nephropathy owing to the DILS was
reported in 1990.6 In a recent report describing 111 DILS
patients, the proportion of ‘renal involvement’ was relatively
high (9%).11 Still, the severity and outcome of DILS-related
renal syndrome are unknown, and no specific therapeutic
guidelines exist (unlike other non-HIVAN renal diseases).12
Here, we describe the clinical course and the histopatho-
logical features of a patient with this rare, but perhaps
a b
dc
Figure 2 | Characterization of infiltrating cells. By immunohistochemistry, the dense cellular infiltrate is composed of (a) some CD20þ
B cells but most are (b) CD3þ (c) CD8þ (clone C8/144b, diluted 1/50, Dako, Trappers, France) T lymphocytes, which have infiltrated
tubules. Some of these infiltrating cells express Granzyme B (clone GrB-7, diluted 1/100, Dako), suggesting (d) a cytolytic activity.
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underestimated, tubulo-interstitial disease. Several characteri-
stics of DILS-related renal involvement can be identified from
our experience and the literature (Table 3). First, patients have
organic renal failure and experience acute flares during the
course of the disease. The renal syndrome is typically
characterized by enlarged kidneys, tubulo-interstitial disease,
and mild-grade proteinuria essentially composed of tubular
proteins. At this stage, a salivary gland biopsy may be
diagnostic and reveal CD8þ lymphocytic infiltration even in
the absence of sicca symptoms (sicca was absent in no less
than 46% of the most recent series11). Second, on renal
biopsy, DILS-related lesions are characterized by acute tubulo-
interstitial nephritis with patchy and dense cellular interstitial
infiltrates comprising lymphocytes, monocytes, and plasma
cells. The renal interstitium is highly expanded by large sheets
of these inflammatory cells. Tubulitis may occur and lead to
tubular destruction. The interstitium may present large sheets
of fibrosis. Glomeruli are spared, except for some pericapsular
fibrosis or glomerulosclerosis in areas where chronic lesions
are most important. Immunophenotyping shows that the
cellular infiltrate is composed predominantly of CD3þ T
lymphocytes, which are all CD8þ , admixed with some
CD20þ B lymphocytes and CD68þ histiocytes.
Differential diagnosis
Renal biopsy is cardinal for differentiating DILS-related
nephropathy from other interstitial nephritis, which can
occur in HIV patients, especially with highly active
antiretroviral therapy (Table 4). The T-cell subset, and
particularly the CD4/CD8 ratio in the infiltrate, is highly
variable in drug-induced nephritis,13,14 and the predomi-
1 2 3 4
Figure 3 | TCRc rearrangement analysis. PCR products from a
multiplex PCR amplification of the g chain gene locus on DNA
extracted from blood and renal biopsy migrated using denaturing
gradient gel electrophoresis (lanes 3 and 4, respectively). As a
sensitivity control, DNA from the Jurkat T-cell line was diluted in DNA
from normal donors peripheral blood monocytes before PCR (lane 1,
10%; lane 2, 1%). Arrows indicate the two alleles of a weakly
dominant T-cell clone detected both in the blood and in the kidney.
A faint oligoclonal pattern (above the intensity of lane 2 sensitivity
control) is also detected.
Table 2 | Characteristic findings of DILS patients
Clinical findings Biological/radiological findings
Sicca symptoms Anti-Ro/SSA; Anti-La/SSB: negative
Parotid gland enlargementa Polyclonal
hypergammaglobulinemia
Xerostomia
Xerophthalmia
Others (rare)
Lymphocytic interstitial
pneumonitisa (dyspnea)
Chest X-ray: bilateral pulmonary
infiltrates
Interstitial nephritisa Ultrasonography: enlarged kidneys
Lymphadenopathya
Lymphocytic gastritisa
Lymphocytic hepatitisa Elevated liver enzymes
Lymphocytic myositisa Elevated creatine phosphokinase
level
Lymphocytic neuropathya
VIIth nerve palsy
Aseptic meningitis CD8+ lymphocytic cerebrospinal
fluid
DILS, diffuse infiltrative lymphocytosis syndrome.
aIndicates that a biopsy may contribute to the diagnosis by showing CD8+
lymphocytic infiltration.
Table 3 | Characteristics of the renal syndrome associated
with DILS
Biological findings
High HIV viral load
CD8+ hyperlymphocytosis (7monoclonal component)
Polyclonal hypergammaglobulinemia
Acute renal failure
Functional tubular disorders (salt waste, distal acidosis, mild grade
proteinuria)
Leucocyturia, hematuria
Ultrasonography findings
Enlarged kidneys
Renal Biopsy findings
Interstitial infiltrates (mostly CD8+ T lymphocytes; absence of CD4+
lymphocytes)
Tubulitis
Tubular atrophy and interstitial fibrosis
Negative findings: glomeruli are spared; absence of granuloma
Treatment
Steroid sensitive flares
Antiviral therapy
DILS, diffuse infiltrative lymphocytosis syndrome.
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nance of CD8þ lymphocytes is of no help to exclude such a
diagnosis. However, our patient had not been exposed to any
drugs, antiviral, or others that might have induced toxic or
immuno-allergic nephritis and he had no clinical or
biological signs of allergy.
Likewise, the diagnosis of immune reconstitution inflamma-
tory syndrome was highly improbable because he did not present
severe CD4 depletion or immune reconstitution, and he had no
documented opportunistic infection on admission or later.
Disseminated tuberculosis was looked for, since it is
commonly seen in HIV patients and, as with DILS, may
involve the lungs, kidneys, and nerves. Our patient had no
epithelioid granuloma in the interstitium, and no Langhans-
type giant cells; Mycobacterium tuberculosum was not found
despite extensive research and no tuberculosis developed
despite steroid therapy and in the absence of antituberculosis
treatment. Thus, we may confidently rule out this diagnosis.
Last but not least, T-cell lymphoma merits discussion.
Most lymphomas develop from B cells in HIV patients,15 but
peripheral T-cell lymphomas with a cytotoxic CD8þ
phenotype have been reported.16 Lymphomatous infiltration
may cause renal failure and enlarge kidneys, and our patient
had a monoclonal component both in his blood and kidneys.
Yet, three arguments plead against this diagnosis: he had no
tumoral syndrome (neither at presentation, nor during the
follow-up during which he received no chemotherapy), the
pathological aspect of the renal tissue was not suggestive of
lymphoma (morphology of lymphocytes was unremarkable,
and no mitotic figures were observed), and the amplification
of the clonal T-cell population was weak. This makes the
diagnosis of a lymphoma highly unlikely. Conversely, Smith
et al.17 reported that a monoclonal CD8þ T-cell population
could be detected in five patients out of 58 with DILS,
without any signs of malignancy. So far, these monoclonal
components are considered to be reactive to HIV infection.
Likewise, in regard of the pathophysiology of this rare
syndrome with polyclonal CD8 expansion, Itescu et al.6
suggested that some immunogenetically distinct individuals
were responding to HIV infection by developing ‘reactive’
circulating CD8þ lymphocytosis, and that lymphocytes were
sequestered into the different organs by interaction with
accessory molecules. But the expansion of CD8þ T cells
could also be due to other viral coinfectants such as EBV or
HTLV1.17,18
Therapeutic considerations
This case suggests that steroids are the therapy of choice in
the severe forms of DILS nephropathy: renal failure was to
some degree sensitive to steroids, with rapid though partial
improvement of renal function. They also improved extra-
renal symptoms (lymphocytic myelitis and gait disorders)
and decreased circulating CD8þ cells.
Table 4 | Clinical and biological features differentiating DILS from its main differential diagnoses
DILS Gougerot–Sjo¨gren
T-cell
lymphoma Tuberculosis
Drug-induced
interstitial nephritis
Clinical
Sicca symptoms + ++   
Lymphadenopathy +  ++ ++ 
Arthralgia  ++ 7  +
Myalgia + ++   
Raynaud phenomenon  +   
Purpura  + 7  +
Interstitial pneumonitis ++ ++ + ++ 
Hepatitis + 7 7 + +
Interstitial nephritis ++ ++ 7 + ++
Distal tubular acidosis + +   +
Hypothyroidism  +   
Central nervous system involvement + + 7 + 
Peripheral neuropathy ++ + 7  
Psychiatric disorders  ++   
Biological
Anti SSA/SSB  +   
ANA  +   
IgM rheumatoid factor  +   
Hypergammaglobulinemia ++ ++  ++ 
HIV +  a 7 
Eosinophiluria     ++
Renal histology
CD4 lymphocytic infiltration  ++ 7 ? ++
CD8 lymphocytic infiltration ++ + 7 ? +
Abnormal lymphocyte morphology   ++  
Eosinophilic infiltrates     ++
Granulomas   ? ++ +
DILS, diffuse infiltrative lymphocytosis syndrome.
aHIV patients usually develop lymphomas from B cells. In most cases, these are diffuse large B-cell lymphomas or Burkitt lymphomas.
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As this CD8 lymphocytosis is considered to be reactive to
HIV infection, and in light of the recent report that the
prevalence of DILS has decreased substantially since the
introduction of highly active antiretroviral therapy,11,19
antiviral therapy should certainly be administered in
combination with steroids. As long as volemia is restored,
and the drugs are appropriately adapted to residual renal
failure, this regimen may be given either simultaneously or a
short time after steroid induction. Whether patients diag-
nosed at an early stage of the disease, and with mild forms of
visceral involvement, including renal, could be completely
spared from steroids and benefit from a sole antiviral therapy
on a curative basis is not known. Of note, no specific
guidelines exist favoring one class of antiviral drug over
another to eradicate DILS; in a recent series, 73% of patients
diagnosed with DILS were receiving antiviral therapy at the
time of presentation with sicca.11 Interestingly enough, we
observed that our patient relapsed while HIV was undetect-
able in his blood, making the relationship between the
control of HIV replication and DILS symptoms somewhat
puzzling. However, discrepancy between the HIV viral load
and the renal syndrome has already been found during the
most frequent form of HIV-related renal disease, HIVAN.20
SUMMARY
DILS should be considered by the nephrologists confronted
by an acute interstitial nephritis occurring in HIVþ patients;
sicca symptoms and CD8 lymphocytosis are strong features
supporting this diagnosis. Renal biopsy is mandatory to
exclude an infectious process or a malignant lymphopro-
liferative syndrome, and to allow the prompt initiation of
adequate therapy, which so far, should comprise an induction
therapy with steroids and drugs targeting HIV replication.
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